BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hayes CN, Chayama K. MicroRNAs as Biomarkers for Liver Disease and Hepatocellular Carcinoma. Int J Mol Sci. 2016;17:280. [PMID: 26927063 DOI: 10.3390/ijms17030280] [Cited by in Crossref: 112] [Cited by in F6Publishing: 109] [Article Influence: 18.7] [Reference Citation Analysis]
Number Citing Articles
1 Du L, Tang H. miRNA antagonism and direct-acting antivirals: could this be a novel combination treatment against HCV? Future Virology 2016;11:753-6. [DOI: 10.2217/fvl-2016-0109] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
2 Shao D, Wang C, Sun Y, Cui L. Effects of oral implants with miR‑122‑modified cell sheets on rat bone marrow mesenchymal stem cells. Mol Med Rep 2018;17:1537-44. [PMID: 29257226 DOI: 10.3892/mmr.2017.8094] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
3 Zou Y, Yang J, Wu J, Luo C, Huang Y. miR-133b induces chemoresistance of osteosarcoma cells to cisplatin treatment by promoting cell death, migration and invasion. Oncol Lett 2018;15:1097-102. [PMID: 29399170 DOI: 10.3892/ol.2017.7432] [Cited by in Crossref: 4] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
4 Hu M, Wang M, Lu H, Wang X, Fang X, Wang J, Ma C, Chen X, Xia H. Loss of miR-1258 contributes to carcinogenesis and progression of liver cancer through targeting CDC28 protein kinase regulatory subunit 1B. Oncotarget 2016;7:43419-31. [PMID: 27270326 DOI: 10.18632/oncotarget.9728] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
5 Zhao Y, Cao J, Melamed A, Worley M, Gockley A, Jones D, Nia HT, Zhang Y, Stylianopoulos T, Kumar AS, Mpekris F, Datta M, Sun Y, Wu L, Gao X, Yeku O, Del Carmen MG, Spriggs DR, Jain RK, Xu L. Losartan treatment enhances chemotherapy efficacy and reduces ascites in ovarian cancer models by normalizing the tumor stroma. Proc Natl Acad Sci U S A 2019;116:2210-9. [PMID: 30659155 DOI: 10.1073/pnas.1818357116] [Cited by in Crossref: 73] [Cited by in F6Publishing: 72] [Article Influence: 24.3] [Reference Citation Analysis]
6 Motawi TK, Mohamed MR, Shahin NN, Ali MA, Azzam MA. Time-course expression profile and diagnostic potential of a miRNA panel in exosomes and total serum in acute liver injury. The International Journal of Biochemistry & Cell Biology 2018;100:11-21. [DOI: 10.1016/j.biocel.2018.05.002] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
7 Lai Y, Ushio N, Rahman MM, Katanoda Y, Ogihara K, Naya Y, Moriyama A, Iwanaga T, Saitoh Y, Sogawa T, Sunaga T, Momoi Y, Izumi H, Miyoshi N, Endo Y, Fujiki M, Kawaguchi H, Miura N. Aberrant expression of microRNAs and the miR-1/MET pathway in canine hepatocellular carcinoma. Vet Comp Oncol 2018;16:288-96. [DOI: 10.1111/vco.12379] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
8 Seclaman E, Balacescu L, Balacescu O, Bejinar C, Udrescu M, Marian C, Sirbu IO, Anghel A. MicroRNAs mediate liver transcriptome changes upon soy diet intervention in mice. J Cell Mol Med 2019;23:2263-7. [PMID: 30618122 DOI: 10.1111/jcmm.14140] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
9 Wang Q, Ye B, Wang P, Yao F, Zhang C, Yu G. Overview of microRNA-199a Regulation in Cancer. Cancer Manag Res 2019;11:10327-35. [PMID: 31849522 DOI: 10.2147/CMAR.S231971] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
10 Abu-Halima M, Meese E, Saleh MA, Keller A, Abdul-Khaliq H, Raedle-Hurst T. MicroRNA-29b/c-3p Indicate Advanced Liver Fibrosis/Cirrhosis in Univentricular Heart Patients With and Without Fontan Palliation. Front Cardiovasc Med 2020;7:619083. [PMID: 33490119 DOI: 10.3389/fcvm.2020.619083] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
11 Petrovic N, Ergun S. miRNAs as Potential Treatment Targets and Treatment Options in Cancer. Mol Diagn Ther 2018;22:157-68. [DOI: 10.1007/s40291-017-0314-8] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 7.0] [Reference Citation Analysis]
12 Sun J, Liu L, Zou H, Yu W. The Long Non-Coding RNA CASC2 Suppresses Cell Viability, Migration, and Invasion in Hepatocellular Carcinoma Cells by Directly Downregulating miR-183. Yonsei Med J 2019;60:905-13. [PMID: 31538425 DOI: 10.3349/ymj.2019.60.10.905] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
13 Fonseca A, Ramalhete SV, Mestre A, Pires das Neves R, Marreiros A, Castelo-Branco P, Roberto VP. Identification of colorectal cancer associated biomarkers: an integrated analysis of miRNA expression. Aging (Albany NY) 2021;13:21991-2029. [PMID: 34547721 DOI: 10.18632/aging.203556] [Reference Citation Analysis]
14 Dutta R, Mahato RI. Recent advances in hepatocellular carcinoma therapy. Pharmacol Ther. 2017;173:106-117. [PMID: 28174094 DOI: 10.1016/j.pharmthera.2017.02.010] [Cited by in Crossref: 120] [Cited by in F6Publishing: 124] [Article Influence: 24.0] [Reference Citation Analysis]
15 Livingstone MC, Johnson NM, Roebuck BD, Kensler TW, Groopman JD. Profound changes in miRNA expression during cancer initiation by aflatoxin B1 and their abrogation by the chemopreventive triterpenoid CDDO-Im. Mol Carcinog 2017;56:2382-90. [PMID: 28218475 DOI: 10.1002/mc.22635] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 3.8] [Reference Citation Analysis]
16 Lv T, Jiang L, Kong L, Yang J. MicroRNA‑29c‑3p acts as a tumor suppressor gene and inhibits tumor progression in hepatocellular carcinoma by targeting TRIM31. Oncol Rep 2020;43:953-64. [PMID: 32020206 DOI: 10.3892/or.2020.7469] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
17 Murray DD, Suzuki K, Law M, Trebicka J, Neuhaus Nordwall J, Johnson M, Vjecha MJ, Kelleher AD, Emery S. Circulating miR-122 and miR-200a as biomarkers for fatal liver disease in ART-treated, HIV-1-infected individuals. Sci Rep 2017;7:10934. [PMID: 28883647 DOI: 10.1038/s41598-017-11405-8] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
18 Chen Y, Yang S, Peng Y, Yang Z. The regulatory role of IL-6R in hepatitis B-associated fibrosis and cirrhosis. Braz J Med Biol Res 2017;50:e6246. [PMID: 28953986 DOI: 10.1590/1414-431X20176246] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
19 Wang J, Guo XJ, Ding YM, Jiang JX. miR-1181 inhibits invasion and proliferation via STAT3 in pancreatic cancer. World J Gastroenterol 2017; 23(9): 1594-1601 [PMID: 28321160 DOI: 10.3748/wjg.v23.i9.1594] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]
20 Rong X, Ailing F, Xiaodong L, Jie H, Min L. Monitoring hepatitis B by using point-of-care testing: biomarkers, current technologies, and perspectives. Expert Rev Mol Diagn 2021;21:195-211. [PMID: 33467927 DOI: 10.1080/14737159.2021.1876565] [Reference Citation Analysis]
21 Chen F, Li XF, Fu DS, Huang JG, Yang SE. Clinical potential of miRNA-221 as a novel prognostic biomarker for hepatocellular carcinoma. Cancer Biomark. 2017;18:209-214. [PMID: 27983537 DOI: 10.3233/cbm-161671] [Cited by in Crossref: 23] [Cited by in F6Publishing: 15] [Article Influence: 4.6] [Reference Citation Analysis]
22 Kong Q, Liang C, Jin Y, Pan Y, Tong D, Kong Q, Zhou J. The lncRNA MIR4435-2HG is upregulated in hepatocellular carcinoma and promotes cancer cell proliferation by upregulating miRNA-487a. Cell Mol Biol Lett 2019;24:26. [PMID: 30988676 DOI: 10.1186/s11658-019-0148-y] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 8.0] [Reference Citation Analysis]
23 Xu F, Yu Y, Yang YH, Liu H, Wang J. Clinical significance of IL-28B expression in HBV related hepatocellular carcinoma. Shijie Huaren Xiaohua Zazhi 2016; 24(12): 1812-1818 [DOI: 10.11569/wcjd.v24.i12.1812] [Reference Citation Analysis]
24 Jin Y, Wang J, Han J, Luo D, Sun Z. MiR-122 inhibits epithelial-mesenchymal transition in hepatocellular carcinoma by targeting Snail1 and Snail2 and suppressing WNT/β-cadherin signaling pathway. Exp Cell Res 2017;360:210-7. [PMID: 28890291 DOI: 10.1016/j.yexcr.2017.09.010] [Cited by in Crossref: 54] [Cited by in F6Publishing: 55] [Article Influence: 10.8] [Reference Citation Analysis]
25 Huo W, Du M, Pan X, Zhu X, Gao Y, Li Z. miR-203a-3p.1 targets IL-24 to modulate hepatocellular carcinoma cell growth and metastasis. FEBS Open Bio 2017;7:1085-91. [PMID: 28781949 DOI: 10.1002/2211-5463.12248] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 3.6] [Reference Citation Analysis]
26 Khodayari N, Oshins R, Holliday LS, Clark V, Xiao Q, Marek G, Mehrad B, Brantly M. Alpha-1 antitrypsin deficient individuals have circulating extracellular vesicles with profibrogenic cargo. Cell Commun Signal 2020;18:140. [PMID: 32887613 DOI: 10.1186/s12964-020-00648-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
27 Zhang S, Chen L, Wang Y, Tang W, Chen Y, Liu L. Investigation of the Association of miRNA-499, miRNA-146a, miRNA-196a2 Loci with Hepatocellular Carcinoma Risk: A Case-Control Study Involving 1507 Subjects. DNA Cell Biol 2020;39:379-88. [PMID: 32031872 DOI: 10.1089/dna.2019.5145] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
28 Shi BM, Lu W, Ji K, Wang YF, Xiao S, Wang XY. Study on the value of serum miR-106b for the early diagnosis of hepatocellular carcinoma. World J Gastroenterol 2017; 23(20): 3713-3720 [PMID: 28611524 DOI: 10.3748/wjg.v23.i20.3713] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
29 Lutz P, M Haimid M, Pohlmann A, Lehmann J, Jansen C, Schierwagen R, Klein S, Strassburg CP, Spengler U, Trebicka J. MicroRNA-155 is upregulated in ascites in patients with spontaneous bacterial peritonitis. Sci Rep 2017;7:40556. [PMID: 28074870 DOI: 10.1038/srep40556] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
30 Wei G, Li S, Wang P, Wang S, Zhao Y. Altered Expression of miR-575 in Glioma is Related to Tumor Cell Proliferation, Migration, and Invasion. Neuromolecular Med 2021. [PMID: 34272655 DOI: 10.1007/s12017-021-08679-7] [Reference Citation Analysis]
31 Campion D, Tucci A, Ponzo P, Caviglia GP. Non-invasive biomarkers for the detection of hepatocellular carcinoma. Minerva Biotecnol 2019;31. [DOI: 10.23736/s1120-4826.18.02488-6] [Cited by in Crossref: 13] [Article Influence: 4.3] [Reference Citation Analysis]
32 Yousefi Z, Nourbakhsh M, Abdolvahabi Z, Ghorbanhosseini SS, Hesari Z, Yarahmadi S, Ezzati-Mobasser S, Seiri P, Borji M, Meshkani R, Malek M. microRNA-141 is associated with hepatic steatosis by downregulating the sirtuin1/AMP-activated protein kinase pathway in hepatocytes. J Cell Physiol 2020;235:880-90. [PMID: 31256424 DOI: 10.1002/jcp.29002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
33 Artells R, Pruna R, Dellal A, Maffulli N. Elastin: a possible genetic biomarker for more severe ligament injuries in elite soccer. A pilot study. Muscles Ligaments Tendons J 2016;6:188-92. [PMID: 27900291 DOI: 10.11138/mltj/2016.6.2.188] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
34 Yousefpouran S, Mostafaei S, Manesh PV, Iranifar E, Bokharaei-salim F, Nahand JS, Mirzaei H, Taran M, Babaei F, Sayad B, Moghoofei M. The assessment of selected MiRNAs profile in HIV, HBV, HCV, HIV/HCV, HIV/HBV Co-infection and elite controllers for determination of biomarker. Microbial Pathogenesis 2020;147:104355. [DOI: 10.1016/j.micpath.2020.104355] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
35 Azeltine MW, Chavez EJ, Nemec KM, Bednarek JM, Asokan R, Balasubramaniyan N, Zgheib C, Mack CL, Roach JP. Inflammation Drives MicroRNAs to Limit Hepatocyte Bile Acid Transport in Murine Biliary Atresia. J Surg Res 2020;256:663-72. [PMID: 32818799 DOI: 10.1016/j.jss.2020.07.003] [Reference Citation Analysis]
36 Chi H, Yang R, Zheng X, Zhang L, Jiang R, Chen J. LncRNA RP11-79H23.3 Functions as a Competing Endogenous RNA to Regulate PTEN Expression through Sponging hsa-miR-107 in the Development of Bladder Cancer. Int J Mol Sci 2018;19:E2531. [PMID: 30149689 DOI: 10.3390/ijms19092531] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 4.8] [Reference Citation Analysis]
37 Riedel R, Pérez-Pérez A, Carmona-Fernández A, Jaime M, Casale R, Dueñas JL, Guadix P, Sánchez-Margalet V, Varone CL, Maymó JL. Human amniotic membrane conditioned medium inhibits proliferation and modulates related microRNAs expression in hepatocarcinoma cells. Sci Rep 2019;9:14193. [PMID: 31578445 DOI: 10.1038/s41598-019-50648-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
38 Wu T, Song H, Xie D, Hua K, Hu J, Deng Y, Ji C, Fang L. Mir-30b-5p Promotes Proliferation, Migration, and Invasion of Breast Cancer Cells via Targeting ASPP2. Biomed Res Int 2020;2020:7907269. [PMID: 32420372 DOI: 10.1155/2020/7907269] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
39 Qin X, Guo Y, Du H, Zhong Y, Zhang J, Li X, Yu H, Zhang Z, Jia Z, Li Z. Comparative Analysis for Glycopatterns and Complex-Type N-Glycans of Glycoprotein in Sera from Chronic Hepatitis B- and C-Infected Patients. Front Physiol 2017;8:596. [PMID: 28871230 DOI: 10.3389/fphys.2017.00596] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
40 Dong X, Wang F, Xue Y, Lin Z, Song W, Yang N, Li Q. MicroRNA‑9‑5p downregulates Klf4 and influences the progression of hepatocellular carcinoma via the AKT signaling pathway. Int J Mol Med 2019;43:1417-29. [PMID: 30664155 DOI: 10.3892/ijmm.2019.4062] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 0.3] [Reference Citation Analysis]
41 Afshari A, Yaghobi R, Karimi MH, Mowla J. Alterations in MicroRNA gene expression profile in liver transplant patients with hepatocellular carcinoma. BMC Gastroenterol 2021;21:262. [PMID: 34118888 DOI: 10.1186/s12876-020-01596-2] [Reference Citation Analysis]
42 Cabral BCA, Hoffmann L, Bottaro T, Costa PF, Ramos ALA, Coelho HSM, Villela-Nogueira CA, Ürményi TP, Faffe DS, Silva R. Circulating microRNAs associated with liver fibrosis in chronic hepatitis C patients. Biochem Biophys Rep 2020;24:100814. [PMID: 33015376 DOI: 10.1016/j.bbrep.2020.100814] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
43 Musaddaq G, Shahzad N, Ashraf MA, Arshad MI. Circulating liver-specific microRNAs as noninvasive diagnostic biomarkers of hepatic diseases in human. Biomarkers 2019;24:103-9. [PMID: 30252499 DOI: 10.1080/1354750X.2018.1528631] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
44 Dong W, Wu P, Qin M, Guo S, Liu H, Yang X, He W, Bouakaz A, Wan M, Zong Y. Multipotent miRNA Sponge-Loaded Magnetic Nanodroplets with Ultrasound/Magnet-Assisted Delivery for Hepatocellular Carcinoma Therapy. Mol Pharm 2020;17:2891-910. [PMID: 32678617 DOI: 10.1021/acs.molpharmaceut.0c00336] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
45 Das K, Garnica O, Dhandayuthapani S. Modulation of Host miRNAs by Intracellular Bacterial Pathogens. Front Cell Infect Microbiol 2016;6:79. [PMID: 27536558 DOI: 10.3389/fcimb.2016.00079] [Cited by in Crossref: 47] [Cited by in F6Publishing: 49] [Article Influence: 7.8] [Reference Citation Analysis]
46 Pant K, Venugopal SK. Circulating microRNAs: Possible role as non-invasive diagnostic biomarkers in liver disease. Clinics and Research in Hepatology and Gastroenterology 2017;41:370-7. [DOI: 10.1016/j.clinre.2016.11.001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
47 Wei R, Yang Q, Han B, Li Y, Yao K, Yang X, Chen Z, Yang S, Zhou J, Li M, Yu H, Yu M, Cui Q. microRNA-375 inhibits colorectal cancer cells proliferation by downregulating JAK2/STAT3 and MAP3K8/ERK signaling pathways. Oncotarget 2017;8:16633-41. [PMID: 28186962 DOI: 10.18632/oncotarget.15114] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 6.2] [Reference Citation Analysis]
48 Deng L, Tang J, Yang H, Cheng C, Lu S, Jiang R, Sun B. MTA1 modulated by miR-30e contributes to epithelial-to-mesenchymal transition in hepatocellular carcinoma through an ErbB2-dependent pathway. Oncogene 2017;36:3976-85. [DOI: 10.1038/onc.2016.491] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 4.2] [Reference Citation Analysis]
49 He S, Sun H, Huang Y, Dong S, Qiao C, Zhang S, Wang C, Zheng F, Yan M, Yang G. Identification and Interaction Analysis of Significant Genes and MicroRNAs in Pterygium. Biomed Res Int 2019;2019:2767512. [PMID: 31341891 DOI: 10.1155/2019/2767512] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
50 Ding W, Tan H, Li X, Zhang Y, Fang F, Tian Y, Li J, Pan X. MicroRNA-493 suppresses cell proliferation and invasion by targeting ZFX in human hepatocellular carcinoma. CBM 2018;22:427-34. [DOI: 10.3233/cbm-171036] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
51 Du H, Xu Q, Xiao S, Wu Z, Gong J, Liu C, Ren G, Wu H. MicroRNA-424-5p acts as a potential biomarker and inhibits proliferation and invasion in hepatocellular carcinoma by targeting TRIM29. Life Sci 2019;224:1-11. [PMID: 30876939 DOI: 10.1016/j.lfs.2019.03.028] [Cited by in Crossref: 19] [Cited by in F6Publishing: 24] [Article Influence: 6.3] [Reference Citation Analysis]
52 Luo Z, Fan Y, Liu X, Liu S, Kong X, Ding Z, Li Y, Wei L. MiR-188-3p and miR-133b Suppress Cell Proliferation in Human Hepatocellular Carcinoma via Post-Transcriptional Suppression of NDRG1. Technol Cancer Res Treat 2021;20:15330338211033074. [PMID: 34355586 DOI: 10.1177/15330338211033074] [Reference Citation Analysis]
53 Chew SA, Moscato S, George S, Azimi B, Danti S. Liver Cancer: Current and Future Trends Using Biomaterials. Cancers (Basel) 2019;11:E2026. [PMID: 31888198 DOI: 10.3390/cancers11122026] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
54 Kamity R, Sharma S, Hanna N. MicroRNA-Mediated Control of Inflammation and Tolerance in Pregnancy. Front Immunol 2019;10:718. [PMID: 31024550 DOI: 10.3389/fimmu.2019.00718] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
55 Lauschke VM. Dysregulation of miR-223 constitutes a promising biomarker that informs about clinical outcomes of acute liver failure. Clin Sci (Lond) 2017;131:2059-62. [PMID: 28729435 DOI: 10.1042/CS20171129] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
56 El-Sebaey AM, Abramov PN, Abdelhamid FM. Clinical Characteristics, Serum Biochemical Changes, and Expression Profile of Serum Cfa-miRNAs in Dogs Confirmed to Have Congenital Portosystemic Shunts Accompanied by Liver Pathologies. Vet Sci 2020;7:E35. [PMID: 32218339 DOI: 10.3390/vetsci7020035] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
57 Budding K, Rossato M, van de Graaf E, Kwakkel-van Erp J, Radstake T, Otten H. Serum miRNAs as potential biomarkers for the bronchiolitis obliterans syndrome after lung transplantation. Transplant Immunology 2017;42:1-4. [DOI: 10.1016/j.trim.2017.04.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
58 Chávez-López MG, Zúñiga-García V, Pérez-Carreón JI, Avalos-Fuentes A, Escobar Y, Camacho J. Eag1 channels as potential early-stage biomarkers of hepatocellular carcinoma. Biologics 2016;10:139-48. [PMID: 27703327 DOI: 10.2147/BTT.S87402] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
59 Yang Z, Peng Y, Yang S. MicroRNA-146a regulates the transformation from liver fibrosis to cirrhosis in patients with hepatitis B via interleukin-6. Exp Ther Med. 2019;17:4670-4676. [PMID: 31086599 DOI: 10.3892/etm.2019.7490] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
60 Ringelhan M, McKeating JA, Protzer U. Viral hepatitis and liver cancer. Philos Trans R Soc Lond B Biol Sci. 2017;372. [PMID: 28893941 DOI: 10.1098/rstb.2016.0274] [Cited by in Crossref: 100] [Cited by in F6Publishing: 94] [Article Influence: 25.0] [Reference Citation Analysis]
61 Oura K, Morishita A, Masaki T. Molecular and Functional Roles of MicroRNAs in the Progression of Hepatocellular Carcinoma-A Review. Int J Mol Sci 2020;21:E8362. [PMID: 33171811 DOI: 10.3390/ijms21218362] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
62 Saber S. Angiotensin II: a key mediator in the development of liver fibrosis and cancer. Bull Natl Res Cent 2018;42. [DOI: 10.1186/s42269-018-0020-7] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
63 Yang L, Xue H, Sun Y, Zhang L, Xue F, Ge R. CircularRNA-9119 protects hepatocellular carcinoma cells from apoptosis by intercepting miR-26a/JAK1/STAT3 signaling. Cell Death Dis 2020;11:605. [PMID: 32732872 DOI: 10.1038/s41419-020-02807-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
64 Liu W, Yin C, Liu Y. Circular RNA circ_0091579 Promotes Hepatocellular Carcinoma Proliferation, Migration, Invasion, and Glycolysis Through miR-490-5p/CASC3 Axis. Cancer Biother Radiopharm 2020. [PMID: 32673066 DOI: 10.1089/cbr.2019.3472] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
65 Hao J, Sun W, Xu H. Pathogenesis of Concanavalin A induced autoimmune hepatitis in mice. Int Immunopharmacol 2022;102:108411. [PMID: 34891001 DOI: 10.1016/j.intimp.2021.108411] [Reference Citation Analysis]
66 Plissonnier ML, Herzog K, Levrero M, Zeisel MB. Non-Coding RNAs and Hepatitis C Virus-Induced Hepatocellular Carcinoma. Viruses. 2018;10. [PMID: 30380697 DOI: 10.3390/v10110591] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
67 Burgos-aceves MA, Cohen A, Paolella G, Lepretti M, Smith Y, Faggio C, Lionetti L. Modulation of mitochondrial functions by xenobiotic-induced microRNA: From environmental sentinel organisms to mammals. Science of The Total Environment 2018;645:79-88. [DOI: 10.1016/j.scitotenv.2018.07.109] [Cited by in Crossref: 41] [Cited by in F6Publishing: 38] [Article Influence: 10.3] [Reference Citation Analysis]
68 Tunissiolli NM, Castanhole-Nunes MMU, Biselli-Chicote PM, Pavarino EC, da Silva RF, da Silva RC, Goloni-Bertollo EM. Hepatocellular Carcinoma: a Comprehensive Review of Biomarkers, Clinical Aspects, and Therapy. Asian Pac J Cancer Prev. 2017;18:863-872. [PMID: 28545181 DOI: 10.22034/apjcp.2017.18.4.863] [Cited by in F6Publishing: 29] [Reference Citation Analysis]
69 Zhang BY, Chai DP, Wu YH, Qiu LP, Zhang YY, Ye ZH, Yu XP. Potential Drug Targets Against Hepatitis B Virus Based on Both Virus and Host Factors. Curr Drug Targets 2019;20:1636-51. [PMID: 31362671 DOI: 10.2174/1389450120666190729115646] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
70 Zhang Z, Zhu W, Liu Z, Liu Y, Chang C, Jiang H, Li R, Xiao Y, Chen W, Hu Q, Wang Q. Aberrant expression of miRNA‐192‐5p contributes to N , N ‐dimethylformamide‐induced hepatic apoptosis. J Appl Toxicol 2020;40:1683-93. [DOI: 10.1002/jat.4028] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
71 Sadri Nahand J, Bokharaei-Salim F, Salmaninejad A, Nesaei A, Mohajeri F, Moshtzan A, Tabibzadeh A, Karimzadeh M, Moghoofei M, Marjani A, Yaghoubi S, Keyvani H. microRNAs: Key players in virus-associated hepatocellular carcinoma. J Cell Physiol 2019;234:12188-225. [PMID: 30536673 DOI: 10.1002/jcp.27956] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 6.5] [Reference Citation Analysis]
72 Selmaj I, Cichalewska M, Namiecinska M, Galazka G, Horzelski W, Selmaj KW, Mycko MP. Global exosome transcriptome profiling reveals biomarkers for multiple sclerosis. Ann Neurol. 2017;81:703-717. [PMID: 28411393 DOI: 10.1002/ana.24931] [Cited by in Crossref: 71] [Cited by in F6Publishing: 70] [Article Influence: 14.2] [Reference Citation Analysis]
73 Zhao Z, Lin CY, Cheng K. siRNA- and miRNA-based therapeutics for liver fibrosis. Transl Res 2019;214:17-29. [PMID: 31476281 DOI: 10.1016/j.trsl.2019.07.007] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
74 Liu T, Yang T, Xu Z, Tan S, Pan T, Wan N, Li S. MicroRNA-193b-3p regulates hepatocyte apoptosis in selenium-deficient broilers by targeting MAML1. Journal of Inorganic Biochemistry 2018;186:235-45. [DOI: 10.1016/j.jinorgbio.2018.06.013] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 7.3] [Reference Citation Analysis]
75 Wang L, Wu J, Xie C. miR-92a promotes hepatocellular carcinoma cells proliferation and invasion by FOXA2 targeting. Iran J Basic Med Sci 2017;20:783-90. [PMID: 28852443 DOI: 10.22038/IJBMS.2017.9010] [Cited by in F6Publishing: 12] [Reference Citation Analysis]
76 Lu T, Hao J, Shen C, Gu G, Zhang J, Xu N. Partial Hepatectomy-Induced Upregulation of miR-1907 Accelerates Liver Regeneration by Activation Autophagy. Biomed Res Int 2018;2018:3817057. [PMID: 30151380 DOI: 10.1155/2018/3817057] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
77 Kim JH, Lee CH, Lee SW. Exosomal Transmission of MicroRNA from HCV Replicating Cells Stimulates Transdifferentiation in Hepatic Stellate Cells. Mol Ther Nucleic Acids. 2019;14:483-497. [PMID: 30753992 DOI: 10.1016/j.omtn.2019.01.006] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 9.3] [Reference Citation Analysis]
78 Han N, Yan L, Wang X, Sun X, Huang F, Tang H. An updated literature review: how HBV X protein regulates the propagation of the HBV. Future Virology 2020;15:649-58. [DOI: 10.2217/fvl-2020-0251] [Reference Citation Analysis]
79 Bao S, Zheng J, Li N, Huang C, Chen M, Cheng Q, Yu K, Chen S, Zhu M, Shi G. Serum MicroRNA Levels as a Noninvasive Diagnostic Biomarker for the Early Diagnosis of Hepatitis B Virus-Related Liver Fibrosis. Gut Liver. 2017;11:860-869. [PMID: 28750488 DOI: 10.5009/gnl16560] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 4.8] [Reference Citation Analysis]
80 Chen W, Wei C, Lee J. Micro RNA ‐let‐7c suppresses hepatitis C virus replication by targeting Bach1 for induction of haem oxygenase‐1 expression. J Viral Hepat 2019;26:655-65. [DOI: 10.1111/jvh.13072] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
81 Wang J, Yu X, Ouyang N, Luo Q, Tong J, Chen T, Li J. Role of DNA methylation regulation of miR-130b expression in human lung cancer using bioinformatics analysis. Journal of Toxicology and Environmental Health, Part A 2019;82:935-43. [DOI: 10.1080/15287394.2019.1667634] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
82 Sartorius K, Makarova J, Sartorius B, An P, Winkler C, Chuturgoon A, Kramvis A. The Regulatory Role of MicroRNA in Hepatitis-B Virus-Associated Hepatocellular Carcinoma (HBV-HCC) Pathogenesis. Cells 2019;8:E1504. [PMID: 31771261 DOI: 10.3390/cells8121504] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 7.7] [Reference Citation Analysis]
83 Lee NH, Kim SJ, Hyun J. MicroRNAs Regulating Hippo-YAP Signaling in Liver Cancer. Biomedicines 2021;9:347. [PMID: 33808155 DOI: 10.3390/biomedicines9040347] [Reference Citation Analysis]
84 Zhang Q, Zhang Q, Li B, Qu Y, Li Z, Lu L, Li R, Cai X. The Diagnosis Value of a Novel Model with 5 Circulating miRNAs for Liver Fibrosis in Patients with Chronic Hepatitis B. Mediators Inflamm 2021;2021:6636947. [PMID: 33727891 DOI: 10.1155/2021/6636947] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
85 Chen X, Zhang Q, Ma W, Lan T, Hong Z, Yuan Y. The Abnormal Expression of MicroRNA-542-3p in Hepatocellular Carcinoma and Its Clinical Significance. Dis Markers 2018;2018:3973250. [PMID: 29606985 DOI: 10.1155/2018/3973250] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
86 Tavabie OD, Karvellas CJ, Salehi S, Speiser JL, Rose CF, Menon K, Prachalias A, Heneghan MA, Agarwal K, Lee WM, McPhail MJW, Aluvihare VR; United States Acute Liver Failure Study Group. A novel microRNA-based prognostic model outperforms standard prognostic models in patients with acetaminophen-induced acute liver failure. J Hepatol 2021;75:424-34. [PMID: 33857547 DOI: 10.1016/j.jhep.2021.03.013] [Reference Citation Analysis]
87 Tadokoro T, Morishita A, Masaki T. Diagnosis and Therapeutic Management of Liver Fibrosis by MicroRNA. Int J Mol Sci 2021;22:8139. [PMID: 34360904 DOI: 10.3390/ijms22158139] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
88 Lambrecht J, Verhulst S, Reynaert H, van Grunsven LA. The miRFIB-Score: A Serological miRNA-Based Scoring Algorithm for the Diagnosis of Significant Liver Fibrosis. Cells 2019;8:E1003. [PMID: 31470644 DOI: 10.3390/cells8091003] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
89 Basu A, Basu P, Lyons TJ. Hepatic Biomarkers in Diabetes as Modulated by Dietary Phytochemicals. In: Patel VB, Preedy VR, editors. Biomarkers in Liver Disease. Dordrecht: Springer Netherlands; 2017. pp. 957-75. [DOI: 10.1007/978-94-007-7675-3_35] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
90 Dong W, Wu P, Zhou D, Huang J, Qin M, Yang X, Wan M, Zong Y. Ultrasound-Mediated Gene Therapy of Hepatocellular Carcinoma Using Pre-microRNA Plasmid-Loaded Nanodroplets. Ultrasound in Medicine & Biology 2020;46:90-107. [DOI: 10.1016/j.ultrasmedbio.2019.09.016] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
91 Duan B, Huang C, Bai J, Zhang YL, Wang X, Yang J, Li J; Department of Medical Oncology, Shaanxi Provincial People’s Hospital, China, Department of Cell Biology and Genetics, School of Basic Medical Sciences, Xi’an Jiaotong University, China, Department of Medical Oncology, Shaanxi Provincial People’s Hospital, China, Department of Neurology, Shaanxi Provincial People’s Hospital, China, Department of Medical Oncology, Shaanxi Provincial People’s Hospital, China, Department of Cell Biology and Genetics, School of Basic Medical Sciences, Xi’an Jiaotong University, China, Department of National & Local Joint Engineering Research Center of Biodiagnostics and Biotherapy, the Second Affiliated Hospital, Xi’an Jiaotong University, China. Multidrug Resistance in Hepatocellular Carcinoma. In: Tirnitz-parker JE, editor. Hepatocellular Carcinoma. Codon Publications; 2019. pp. 141-58. [DOI: 10.15586/hepatocellularcarcinoma.2019.ch8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
92 Lu J, Zhao Z, Ma Y. miR-186 Represses Proliferation, Migration, Invasion, and EMT of Hepatocellular Carcinoma via Directly Targeting CDK6. Oncol Res 2020;28:509-18. [PMID: 32698940 DOI: 10.3727/096504020X15954139263808] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
93 Shi W, He JJ, Mei XF, Lu KJ, Zeng ZX, Zhang YY, Sheng ZA, Elsheikha HM, Huang WY, Zhu XQ. Dysregulation of hepatic microRNA expression in C57BL/6 mice affected by excretory-secretory products of Fasciola gigantica. PLoS Negl Trop Dis 2020;14:e0008951. [PMID: 33332355 DOI: 10.1371/journal.pntd.0008951] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
94 Marin DE, Braicu C, Dumitrescu G, Pistol GC, Cojocneanu R, Neagoe IB, Taranu I. MicroRNA profiling in kidney in pigs fed ochratoxin A contaminated diet. Ecotoxicol Environ Saf 2019;184:109637. [PMID: 31499447 DOI: 10.1016/j.ecoenv.2019.109637] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
95 Ma Y, Ma M, Ma L, Zhang F, Liu Y, Ma X. Downregulation of miR-552 in hepatocellular carcinoma inhibits cell migration and invasion, and promotes cell apoptosis via RUNX3. Exp Ther Med 2019;18:3829-36. [PMID: 31656538 DOI: 10.3892/etm.2019.8061] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
96 Chandel R, Saxena R, Das A, Kaur J. Association of rno‐miR‐183‐96‐182 cluster with diethyinitrosamine induced liver fibrosis in Wistar rats. J Cell Biochem 2018;119:4072-84. [DOI: 10.1002/jcb.26583] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
97 Pennisi G, Celsa C, Giammanco A, Spatola F, Petta S. The Relevance of Noninvasive Tools To Assess Fibrosis in Non-Alcoholic Fatty Liver Disease. Curr Pharm Des 2020;26:3928-38. [PMID: 32436818 DOI: 10.2174/1381612826666200521133307] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
98 Chen T, Qin S, Gu Y, Pan H, Bian D. Long non-coding RNA NORAD promotes the occurrence and development of non-small cell lung cancer by adsorbing MiR-656-3p. Mol Genet Genomic Med 2019;7:e757. [PMID: 31207175 DOI: 10.1002/mgg3.757] [Cited by in Crossref: 14] [Cited by in F6Publishing: 21] [Article Influence: 4.7] [Reference Citation Analysis]
99 Vogt J, Sheinson D, Katavolos P, Irimagawa H, Tseng M, Alatsis KR, Proctor WR. Variance component analysis of circulating miR-122 in serum from healthy human volunteers. PLoS One 2019;14:e0220406. [PMID: 31348817 DOI: 10.1371/journal.pone.0220406] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
100 Rahman MA, Patters BJ, Kodidela S, Kumar S. Extracellular Vesicles: Intercellular Mediators in Alcohol-Induced Pathologies. J Neuroimmune Pharmacol 2020;15:409-21. [PMID: 30955131 DOI: 10.1007/s11481-019-09848-z] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
101 Dong X, Ding W, Ye J, Yan D, Xue F, Xu L, Yin J, Guo W. MiR-24-3p enhances cell growth in hepatocellular carcinoma by targeting metallothionein 1M. Cell Biochem Funct 2016;34:491-6. [PMID: 27650047 DOI: 10.1002/cbf.3213] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
102 Ouyang X, Wang Z, Yao L, Zhang G. Elevated CELSR3 expression is associated with hepatocarcinogenesis and poor prognosis. Oncol Lett 2020;20:1083-92. [PMID: 32724347 DOI: 10.3892/ol.2020.11671] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
103 Huang KT, Kuo IY, Tsai MC, Wu CH, Hsu LW, Chen LY, Kung CP, Cheng YF, Goto S, Chou YW, Chen CL, Lin CC, Chen KD. Factor VII-Induced MicroRNA-135a Inhibits Autophagy and Is Associated with Poor Prognosis in Hepatocellular Carcinoma. Mol Ther Nucleic Acids 2017;9:274-83. [PMID: 29246306 DOI: 10.1016/j.omtn.2017.10.002] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
104 Sun XF, Sun JP, Hou HT, Li K, Liu X, Ge QX. MicroRNA-27b exerts an oncogenic function by targeting Fbxw7 in human hepatocellular carcinoma. Tumour Biol 2016;37:15325-32. [PMID: 27704356 DOI: 10.1007/s13277-016-5444-9] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
105 Newman LA, Sorich MJ, Rowland A. Role of Extracellular Vesicles in the Pathophysiology, Diagnosis and Tracking of Non-Alcoholic Fatty Liver Disease. J Clin Med 2020;9:E2032. [PMID: 32610455 DOI: 10.3390/jcm9072032] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
106 Wu Z, He L, Wang L, Peng L. Systematically Exploring the Antitumor Mechanisms of Core Chinese Herbs on Hepatocellular Carcinoma: A Computational Study. Evid Based Complement Alternat Med 2020;2020:2396569. [PMID: 33014099 DOI: 10.1155/2020/2396569] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
107 Chen QQ, Zhang C, Qin MQ, Li J, Wang H, Xu DX, Wang JQ. Inositol-Requiring Enzyme 1 Alpha Endoribonuclease Specific Inhibitor STF-083010 Alleviates Carbon Tetrachloride Induced Liver Injury and Liver Fibrosis in Mice. Front Pharmacol 2018;9:1344. [PMID: 30538632 DOI: 10.3389/fphar.2018.01344] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
108 Qiu H, Zhang G, Song B, Jia J. MicroRNA-548b inhibits proliferation and invasion of hepatocellular carcinoma cells by directly targeting specificity protein 1. Exp Ther Med 2019;18:2332-40. [PMID: 31452716 DOI: 10.3892/etm.2019.7812] [Cited by in Crossref: 2] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
109 Ziogas IA, Sioutas G, Mylonas KS, Tsoulfas G. Role of MicroRNA in the Diagnosis and Management of Hepatocellular Carcinoma. Microrna 2020;9:25-40. [PMID: 31218966 DOI: 10.2174/2211536608666190619155406] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
110 Sessa F, Salerno M, Di Mizio G, Bertozzi G, Messina G, Tomaiuolo B, Pisanelli D, Maglietta F, Ricci P, Pomara C. Anabolic Androgenic Steroids: Searching New Molecular Biomarkers. Front Pharmacol 2018;9:1321. [PMID: 30524281 DOI: 10.3389/fphar.2018.01321] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 4.5] [Reference Citation Analysis]
111 de Freitas RCC, Bortolin RH, Lopes MB, Tamborlin L, Meneguello L, Silbiger VN, Hirata RDC, Hirata MH, Luchessi AD, Luchessi AD. Modulation of miR-26a-5p and miR-15b-5p Exosomal Expression Associated with Clopidogrel-Induced Hepatotoxicity in HepG2 Cells. Front Pharmacol 2017;8:906. [PMID: 29311920 DOI: 10.3389/fphar.2017.00906] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
112 Gholizadeh M, Szelag-Pieniek S, Post M, Kurzawski M, Prieto J, Argemi J, Drozdzik M, Kaderali L. Identifying Differentially Expressed MicroRNAs, Target Genes, and Key Pathways Deregulated in Patients with Liver Diseases. Int J Mol Sci 2020;21:E7368. [PMID: 33036164 DOI: 10.3390/ijms21197368] [Reference Citation Analysis]